Aurobindo Pharma Limited said, the company’s unit - IX, Sangareddy District, inspected by the United States Food and Drug Administration (US FDA) from November 10 to November 18, 2022, has now been classified as Voluntary Action Indicated (VAI), via an exchange filing.
The unit is an API intermediate facility situated at Gundlamachnoor Village, Sangareddy District, Telangana.
The disclosure is pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Mumbai News: Deaf Associations Oppose SC PIL Seeking Compulsory ASL In Schools, Demand Protection Of Indian Sign Language
Punjab News: Akali MP Harsimrat Kaur Badal Urges EAM S Jaishankar To Intervene As US Freezes Work Visas Of Punjabi Truck Drivers
Mumbai Cyber Fraud: 49-Year-Old Police Inspector Loses ₹2.99 Lakh After Downloading Fake ‘RTO Chalan’ APK; Case Registered
Mumbai News: BMC Warns Against Crowding On 12 Unsafe Bridges During Ganeshotsav 2025, Issues Strict Restrictions
